kabutan

KAKEN PHARMA, 72% Decrease in Ordinary Profit for The Current Fiscal Year

Mon May 12, 2025 3:30 pm JST Earnings

4521 KAKEN PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

KAKEN PHARMACEUTICAL CO.,LTD. <4521> [TSE Prime] announced its financial results after the market closed on May 12th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 expanded 2.1 times that of the previous period to 21.2 billion yen. However, for the fiscal year ending March 2026 is also bleak, with an expected significant drop by 71.8% from the previous period to 6 billion yen.

In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit/loss turned to a loss of 4.8 billion yen (compared to a profit of 0.64 billion yen in the same period last year). The operating profit/loss margin drastically worsened from 3.7% in the same period last year to -24.3%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 72,984 7,998 8,727 5,440 144.8 150 May 10, 2023 J-GAAP
Mar, 2024 72,044 9,513 9,951 8,025 212.7 150 May 14, 2024 J-GAAP
Mar, 2025 94,035 21,034 21,279 13,945 365.4 190 May 12, 2025 J-GAAP
YoY +30.5% +121.1% +113.8% +73.8% +71.8%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 94,000 20,800 21,000 14,000 364.6 190 Apr 8, 2025 J-GAAP
Mar, 2025 Results 94,035 21,034 21,279 13,945 365.4 190 May 12, 2025 J-GAAP
Revision Rate +0.0% +1.1% +1.3% -0.4% +0.2%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 51,372 19,579 19,823 14,286 377.2 115 Nov 8, 2024 J-GAAP
Apr - Sep, 2025 Guidance ー ー ー ー － 95 May 12, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 72,044 9,513 9,951 8,025 212.7 150 May 14, 2024 J-GAAP
Mar, 2025 94,035 21,034 21,279 13,945 365.4 190 May 12, 2025 J-GAAP
Mar, 2026 Guidance 88,000 5,200 6,000 3,400 89.8 190 May 12, 2025 J-GAAP
YoY -6.4% -75.3% -71.8% -75.6% -75.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 17,359 640 647 1,350 35.8 3.7 May 14, 2024 J-GAAP
Apr - Jun, 2024 18,254 2,750 3,011 1,754 46.3 15.1 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 33,118 16,829 16,812 12,532 330.9 50.8 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 24,618 5,841 6,258 4,889 129.1 23.7 Feb 6, 2025 J-GAAP
Jan - Mar, 2025 18,045 -4,386 -4,802 -5,230 -137.1 -24.3 May 12, 2025 J-GAAP
YoY +4.0% － － － －

Related Articles